Although miR-96 and miR-183 have been suggested to be oncogenic, promoting tumor cell migration and invasion in various cancers [23–26], studies have also shown that they play a critical role in epithelial-mesenchymal transition, via inhibition of cell migration and invasion, downstream of the p53-p21 pathway [27]. This evidence concerns the gene TP53 and cancer.